E. Ashley Gulyas, PharmD

home / authors / e-ashley-gulyas-pharmd

Articles

Pharmacist Feature Friday: A Pharmacist's Compassion Inspired Me to Attend Pharmacy School

Pharmacist Feature Friday: A Pharmacist's Compassion Inspired Me to Attend Pharmacy School

E. Ashley Gulyas, PharmD
March 16th 2018

An interaction with passionate pharmacist and co-worker caused E. Ashley Gulyas, PharmD, to enroll in pharmacy school after nearly a decade of work as a pharmacy technician.

Read More

Pharmacist Feature Friday: A Pharmacist's Compassion Inspired Me to Attend Pharmacy School

Pharmacist Feature Friday: A Pharmacist's Compassion Inspired Me to Attend Pharmacy School

E. Ashley Gulyas, PharmD
March 16th 2018

An interaction with passionate pharmacist and co-worker caused E. Ashley Gulyas, PharmD, to enroll in pharmacy school after nearly a decade of work as a pharmacy technician.

Read More

Latest Updated Articles

AI patient pharmacist provider interactions ASHP summer
Published: June 11th 2024 | Updated: July 27th 2024
Balancing Trust and Technology: The Role of AI in Patient-Pharmacist Interactions
AI pharmacy futures AI disparities skin
Published: June 11th 2024 | Updated: July 27th 2024
Addressing Disparities in AI-Driven Diagnostics: Ethical and Practical Implications
Vice President Kamala Harris -- Image credit: Erin Schaff/Pool/AFP | GETTY | People.com
Published: July 23rd 2024 | Updated: July 27th 2024
VP Kamala Harris’s Policies and Stances on Health Care, Reproductive Rights Take Center Stage
3d illustration of Abstract medical background with Diseased liver - Image credit: Rasi | stock.adobe.com
Published: October 18th 2023 | Updated: July 27th 2024
Pharmacists Can Optimize Treatment for Patients with NASH, Decreasing Economic Burden
Small vial of influenza vaccine.
Published: July 23rd 2024 | Updated: July 27th 2024
Trivalent Influenza Vaccines Are Readied for Fall
Eye Care Pharmacy | Image Credit: I Viewfinder - stock.adobe.com
Published: July 15th 2024 | Updated: July 27th 2024
Biosimilar Ranibizumab Could be More Cost-Effective Than Aflibercept for nAMD